Kickstarted medical device startup Scanadu, which produces the Scout diagnostic tool, said it will drop support for the Scout devices beginning May 15 next year.
The Scanadu Scout is a sensor-packed hand-held scanner which measures body temperature, respiratory rate, oximetry, ECG, systolic blood pressure and diastolic blood pressure with just 10 seconds of contact with the forehead.
Data from the device was transmitted to a smartphone, and collected information could be transmitted to physicians, according to the company.
Support is being withdrawn due to a lack of full FDA approval – the device had previously been cleared only as an investigational device, according to a TechCrunch report.
The Scout was a product of the X Prize Foundation’s Qualcomm Tricorder competition, and went on to raise $1.6 million at Indiegogo, breaking fundraising records on the site.
“From the beginning of the campaign, this was an investigational device that was part of a study which has now reached its endpoint with data collection for the study ending in November 2016. FDA regulations require that all investigational studies be brought to closure and their respective devices be deactivated. As a result, we will deactivate the Scanadu Scout devices by May 15, 2017,” a Scanadu spokesperson said, according to TechCrunch.
Data collected from the devices is being used in an 18 month Scripps Translational Science Institute study survey, which is planned to be issued in May next year, according to the TechCrunch report.